← Back to Search

NA

New Treatment for Lung Cancer

N/A
Waitlist Available
Led By Dennis Wigle, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient must be > 18 years of age
No evidence of distant metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing a new treatment for lung cancer that has spread to other parts of the body.

Who is the study for?
This trial is for adults over 18 with multifocal lung adenocarcinoma, no distant metastases, and capable lungs for surgery. It's not for pregnant women or those who've had other cancers (except certain early-stage ones), prior chest radiation, chemotherapy, or lung cancer surgery.Check my eligibility
What is being tested?
The study aims to evaluate the safety and outcomes of a combined treatment approach for patients with multifocal bronchioloalveolar carcinoma (BAC), a form of non-small cell lung cancer.See study design
What are the potential side effects?
While specific side effects are not listed here, multimodality treatments can include surgery, radiation, and/or chemotherapy which may cause fatigue, pain at the surgical site, breathing difficulties post-surgery, skin irritation from radiation and various chemo-related side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
My cancer has not spread to distant parts of my body.
Select...
My lung function tests show I can undergo lung surgery.
Select...
I am a woman who can have children and have a negative pregnancy test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Survival
Secondary outcome measures
Post-treatment Pulmonary Function
Progressive free survival
Treatment Morbidity and Mortality

Trial Design

1Treatment groups
Experimental Treatment
Group I: Multifocal Lung AdenocarcinomaExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,684 Total Patients Enrolled
Dennis Wigle, MD, PhDPrincipal InvestigatorMayo Clinic
9 Previous Clinical Trials
862 Total Patients Enrolled

Media Library

Multifocal Lung Adenocarcinoma (NA) Clinical Trial Eligibility Overview. Trial Name: NCT01946100 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment have open enrollment at present?

"According to details posted on clinicaltrials.gov, this study is no longer enrolling new patients; the trial was initially published in October of 2013 and last updated at the end of 2021. However, there are presently 2,501 active trials seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Treatment of Multifocal Lung Adenocarcinoma
Dennis Wigle 2013. "Treatment of Multifocal Lung Adenocarcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01946100.
All > Adenocarcinoma > Lung Cancer
~12 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top